Titlebook: Current Treatment Options for Fuchs Endothelial Dystrophy; Claus Cursiefen,Albert S. Jun Book 2017 Springer International Publishing Switz

名字

mastopexy

草率男

MicroRNAs in FECD: A New Therapeutic Option?,ongenital cataract, and stromal thinning (EDICT syndrome). Improved understanding of the role of miRNAs in physiological and pathological conditions of the corneal endothelium may provide us with new strategies to treat corneal endothelial diseases.

灿烂

迅速飞过

没有贫穷

形状

Die Verarbeitung der Kali-Endlauge,h more predictable refractive outcome, reduced risk of immunological rejection, and many more advantages over DSEK and PK. It is a surgery which is readily accessible to any cornea surgeon in any ophthalmology setup. A structured approach with careful attention to the key elements will help ensure success.

狂怒

航海太平洋

只有